Daruwala Paul 4
4 · Cidara Therapeutics, Inc. · Filed Jan 6, 2020
Insider Transaction Report
Form 4
Daruwala Paul
Chief Medical Officer
Transactions
- Sale
Common Stock
2020-01-03$3.42/sh−2,340$8,003→ 53,532 total
Footnotes (1)
- [F1]Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs on 12/31/19. These sales are mandated by the Reporting Person's election to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.